Global Urolithiasis Management Device
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Urolithiasis Management Device market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Urolithiasis Management Device market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Device Type Outlook: Segment Analysis | Shock Wave Lithotripters, Ultrasonic Lithotripters, Pneumatic Lithotripters, Laser Lithotripters, Ureterorenoscopes |
| End User Outlook: Segment Analysis | Hospitals, Ambulatory Surgical Centers (ASCs), Clinics |
| Regions & Countries Analysis |
|
|---|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Urolithiasis Management Device Market Report 2025.
According to Cognitive Market Research, the global Urolithiasis Management Devices market size will be USD 1628.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Urolithiasis Management Device Market Sales Revenue | xxxx | $ 1628.9 Million | $ 2499.85 Million | 5.5% |
| North America Urolithiasis Management Device Market Sales Revenue | xxxx | $ 602.69 Million | $ 781.4 Million | 3.3% |
| United States Urolithiasis Management Device Market Sales Revenue | xxxx | $ 475.52 Million | xxxx | 3.1% |
| Canada Urolithiasis Management Device Market Sales Revenue | xxxx | $ 72.32 Million | xxxx | 4.1% |
| Mexico Urolithiasis Management Device Market Sales Revenue | xxxx | $ 54.85 Million | xxxx | 3.8% |
| Europe Urolithiasis Management Device Market Sales Revenue | xxxx | $ 472.38 Million | $ 636.6 Million | 3.8% |
| United Kingdom Urolithiasis Management Device Market Sales Revenue | xxxx | $ 79.36 Million | xxxx | 4.6% |
| France Urolithiasis Management Device Market Sales Revenue | xxxx | $ 43.46 Million | xxxx | 3% |
| Germany Urolithiasis Management Device Market Sales Revenue | xxxx | $ 93.53 Million | xxxx | 4% |
| Italy Urolithiasis Management Device Market Sales Revenue | xxxx | $ 40.62 Million | xxxx | 3.2% |
| Russia Urolithiasis Management Device Market Sales Revenue | xxxx | $ 73.22 Million | xxxx | 2.8% |
| Spain Urolithiasis Management Device Market Sales Revenue | xxxx | $ 38.74 Million | xxxx | 2.9% |
| Sweden Urolithiasis Management Device Market Sales Revenue | xxxx | $ 14.64 Million | xxxx | 3.9% |
| Denmark Urolithiasis Management Device Market Sales Revenue | xxxx | $ 9.92 Million | xxxx | 3.6% |
| Switzerland Urolithiasis Management Device Market Sales Revenue | xxxx | $ 7.09 Million | xxxx | 3.5% |
| Luxembourg Urolithiasis Management Device Market Sales Revenue | xxxx | $ 5.67 Million | xxxx | 4.1% |
| Rest of Europe Urolithiasis Management Device Market Sales Revenue | xxxx | $ 66.13 Million | xxxx | 2.5% |
| Asia Pacific Urolithiasis Management Device Market Sales Revenue | xxxx | $ 390.94 Million | $ 697.2 Million | 7.5% |
| China Urolithiasis Management Device Market Sales Revenue | xxxx | $ 164.19 Million | xxxx | 7% |
| Japan Urolithiasis Management Device Market Sales Revenue | xxxx | $ 53.95 Million | xxxx | 6% |
| South Korea Urolithiasis Management Device Market Sales Revenue | xxxx | $ 46.91 Million | xxxx | 6.6% |
| India Urolithiasis Management Device Market Sales Revenue | xxxx | $ 39.09 Million | xxxx | 9.4% |
| Australia Urolithiasis Management Device Market Sales Revenue | xxxx | $ 20.33 Million | xxxx | 6.8% |
| Singapore Urolithiasis Management Device Market Sales Revenue | xxxx | $ 7.82 Million | xxxx | 7.8% |
| Taiwan Urolithiasis Management Device Market Sales Revenue | xxxx | $ 15.25 Million | xxxx | 7.3% |
| South East Asia Urolithiasis Management Device Market Sales Revenue | xxxx | $ 25.8 Million | xxxx | 8.3% |
| Rest of APAC Urolithiasis Management Device Market Sales Revenue | xxxx | $ 17.59 Million | xxxx | 7.3% |
| South America Urolithiasis Management Device Market Sales Revenue | xxxx | $ 61.9 Million | $ 88 Million | 4.5% |
| Brazil Urolithiasis Management Device Market Sales Revenue | xxxx | $ 26.49 Million | xxxx | 5.1% |
| Argentina Urolithiasis Management Device Market Sales Revenue | xxxx | $ 10.4 Million | xxxx | 5.4% |
| Colombia Urolithiasis Management Device Market Sales Revenue | xxxx | $ 5.51 Million | xxxx | 4.3% |
| Peru Urolithiasis Management Device Market Sales Revenue | xxxx | $ 5.08 Million | xxxx | 4.7% |
| Chile Urolithiasis Management Device Market Sales Revenue | xxxx | $ 4.46 Million | xxxx | 4.8% |
| Rest of South America Urolithiasis Management Device Market Sales Revenue | xxxx | $ 9.97 Million | xxxx | 3.6% |
| Middle East Urolithiasis Management Device Market Sales Revenue | xxxx | $ 65.16 Million | $ 94.8 Million | 4.8% |
| Qatar Urolithiasis Management Device Market Sales Revenue | xxxx | $ 5.21 Million | xxxx | 4.3% |
| Saudi Arabia Urolithiasis Management Device Market Sales Revenue | xxxx | $ 22.93 Million | xxxx | 5.1% |
| Turkey Urolithiasis Management Device Market Sales Revenue | xxxx | $ 5.21 Million | xxxx | 5.4% |
| UAE Urolithiasis Management Device Market Sales Revenue | xxxx | $ 13.42 Million | xxxx | 5.3% |
| Egypt Urolithiasis Management Device Market Sales Revenue | xxxx | $ 3.91 Million | xxxx | 4.6% |
| Rest of Middle East Urolithiasis Management Device Market Sales Revenue | xxxx | $ 14.46 Million | xxxx | 4% |
| Africa Urolithiasis Management Device Market Sales Revenue | xxxx | $ 35.84 Million | $ 53.8 Million | 5.2% |
| Nigeria Urolithiasis Management Device Market Sales Revenue | xxxx | $ 2.87 Million | xxxx | 5.4% |
| South Africa Urolithiasis Management Device Market Sales Revenue | xxxx | $ 12.61 Million | xxxx | 6.1% |
Urolithiasis Management Device Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The urolithiasis management devices market is experiencing steady growth due to the rising global prevalence of kidney stones and the increasing demand for minimally invasive treatments. Valued at approximately USD 1.58 billion in 2022, the market is projected to reach USD 2.21 billion by 2030, growing at a CAGR of 4.9%. Key drivers include advancements in technologies like intracorporeal lithotripsy and extracorporeal shock wave lithotripsy (ESWL), which offer effective stone removal with reduced patient discomfort. In India, the market is expected to grow at a CAGR of 5.4% from 2025 to 2030, reaching USD 105.1 million by 2030. Major players such as Boston Scientific, Olympus, and Siemens Healthcare are investing in innovative solutions to meet the growing demand for efficient urolithiasis management.
In May 2023, Kidney stones are most common in those between the ages of 30 and 60, according to NHS data. The prevalence of kidney stones is significant, with up to two out of 20 females and almost three out of 20 males experiencing kidney stones. Nephrolithiasis is the medical term for kidney stones, while renal colic is the term for the painful illness. A report from St. Pete Urology states that approximately 500,000 Americans need emergency kidney stone treatment annually. https://pmc.ncbi.nlm.nih.gov/articles/PMC9914194/
The rising prevalence of kidney stones globally is a key driver propelling market growth for related medical devices. Increasing incidences, driven by poor dietary habits, sedentary lifestyles, and dehydration, have led to higher demand for advanced diagnostic and treatment solutions. Minimally invasive procedures such as ureteroscopy and extracorporeal shock wave lithotripsy (ESWL) are gaining popularity due to reduced recovery times and improved patient outcomes. Growing awareness and early diagnosis through improved imaging technologies further support device adoption. As healthcare infrastructure advances, especially in emerging economies, the demand for kidney stone management devices is expected to witness sustained and robust growth.
Advancements in minimally invasive technologies are key drivers propelling market growth by offering improved treatment outcomes, reduced recovery times, and lower risks of complications. These innovations enhance patient satisfaction and drive higher adoption rates among healthcare providers. Technologies such as robotic-assisted surgeries, laser therapies, and image-guided interventions minimize tissue damage and improve precision, leading to better clinical results. Moreover, the growing demand for outpatient procedures and reduced hospital stays supports the shift toward minimally invasive approaches. This trend, coupled with continuous R&D investments and rising awareness, positions minimally invasive technologies as a dominant force in shaping the future of medical treatment markets.
The limited accessibility for low-income patient populations due to high product and treatment costs. Advanced medical technologies, particularly in digital health and specialized therapies, often come with significant upfront and maintenance expenses. These costs can be prohibitive for individuals without comprehensive insurance coverage or government healthcare support. Additionally, the lack of infrastructure and digital literacy in underserved regions further restricts adoption. This economic barrier results in unequal access, limiting the market's full potential and contributing to health disparities. Addressing affordability and expanding subsidized programs are essential to overcoming this constraint and ensuring inclusive healthcare access.
The Trump-era tariffs, particularly those imposed on medical devices and components imported from China, have had a notable impact on the Urolithiasis Management Devices Market.
These Tariffs of 10–25% on Chinese imports raised the cost of raw materials and components (like catheters, scopes, and lithotripsy parts) used in urolithiasis devices. Manufacturers in the US and other countries reliant on Chinese supply chains faced higher operational expenses, leading to increased product prices.
Many companies sought to diversify sourcing to avoid tariffs, which disrupted established supply chains. This shift led to delays in production, increased logistics complexity, and higher short-term costs for alternative sourcing (e.g., from India, Vietnam, or domestic suppliers).
Higher manufacturing costs were partially passed on to hospitals and clinics, raising procurement costs. In some regions, this led to delayed purchases or preference for refurbished devices, affecting new device sales. While the market continued to grow due to rising kidney stone prevalence and demand for minimally invasive treatments, the Trump tariffs temporarily slowed growth, impacted profit margins, and drove strategic reshuffling within the industry
We have various report editions of Urolithiasis Management Device Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
?The urolithiasis management devices market is moderately competitive, featuring key players such as Boston Scientific Corporation, Cook Medical, Olympus Corporation, Karl Storz GmbH & Co. KG, and Siemens Healthineers AG. These companies leverage strategies like product innovations, strategic acquisitions, and technological advancements to maintain market presence. For instance, Boston Scientific's acquisition of Lumenis' global surgical business in March 2021 expanded its kidney stone management offerings. Coloplast AS's July 2023 launch of the TFL Drive, a thulium fibre laser system, also exemplifies the market's trend toward minimally invasive treatments. Such innovations are pivotal in addressing the rising prevalence of kidney diseases globally
In July 2020, Lumenis Ltd. unveiled MOSES 2.0, marking a significant leap forward as the next-generation evolution of their versatile and patented MOSES platform, specifically designed to enhance the landscape of urology care and treatment options. https://www.bostonscientific.com/en-IN/products/lithotripsy/lumenis-pulse-120h.html In June 2020, Olympus Corporation introduced the Soltive SuperPulsed Laser System, which leverages thulium fibre technology for enhanced stone lithotripsy and precise soft tissue applications in urology. This system offers faster and more efficient procedures. https://www.olympus-europa.com/company/en/news/press-releases/2020-06-17t08-50-00/olympus-launches-the-soltive-superpulsed-thulium-fiber-laser-system-for-urology.html
Top Companies Market Share in Urolithiasis Management Device Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| * Allengers | xxxx | xxxx | xxxx | xxxx |
| * Boston Scientific | xxxx | xxxx | xxxx | xxxx |
| * BD | xxxx | xxxx | xxxx | xxxx |
| * Cook Medical | xxxx | xxxx | xxxx | xxxx |
| * ConMed | xxxx | xxxx | xxxx | xxxx |
| * DirexGroup | xxxx | xxxx | xxxx | xxxx |
| * Dornier MedTech | xxxx | xxxx | xxxx | xxxx |
| * KARL STORZ | xxxx | xxxx | xxxx | xxxx |
| * Potent Optotronic | xxxx | xxxx | xxxx | xxxx |
| * HealthTronics | xxxx | xxxx | xxxx | xxxx |
| * Lumenis | xxxx | xxxx | xxxx | xxxx |
| * Olympus | xxxx | xxxx | xxxx | xxxx |
| * Richard Wolf | xxxx | xxxx | xxxx | xxxx |
| * Siemens Healthcare | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Urolithiasis Management Devices market, and the high prevalence of kidney stones, advanced healthcare infrastructure, and increased adoption of minimally invasive procedures. Conversely, the Asia Pacific region is expected to experience the fastest growth, with a projected compound annual growth rate (CAGR) of 6.4% during the forecast period. This growth is driven by a large population base, rising healthcare expenditures, and increasing awareness about urolithiasis treatments.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This growth is driven by factors such as increasing healthcare spending, an ageing population, and the adoption of advanced medical technologies. The rising prevalence of kidney stones in countries like China and India further contributes to this expansion. In contrast, North America currently leads the global market in revenue, owing to its sophisticated healthcare infrastructure and high incidence of urolithiasis.
The current report Scope analyzes Urolithiasis Management Device Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 602.69 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Urolithiasis Management Devices market with a market size of USD 475.52 million in 2025 and is projected to grow at a CAGR of 3.1% during the forecast period. The U.S. Market's technological advancements.
The Canadian Urolithiasis Management Devices market had a market share of USD 72.32 million in 2025 and is projected to grow at a CAGR of 4.1% during the forecast period. Canada’s innovation, healthcare demand.
The Mexico Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 54.85 million in 2025..
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 472.38 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2033.
The United Kingdom Urolithiasis Management Devices market had a market share of USD 79.36 million in 2025 and is projected to grow at a CAGR of 4.6% during the forecast period. In the UK, Urolithiasis Management Devices sales witnessed an upswing due to advanced healthcare systems and increasing demand .
The France Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 43.46 million in 2025.
According to Cognitive Market Research, the German Urolithiasis Management Devices market size was valued at USD 93.53 million in 2025 and is projected to grow at a CAGR of 4.0% during the forecast period. In Germany, advanced healthcare infrastructure and rising urolithiasis cases
The Italy Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 40.62 million in 2025.
The Russia Urolithiasis Management Devices market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 73.22 million in 2025
The Spain Urolithiasis Management Devices market is projected to witness growth at a CAGR of 2.9% during the forecast period with a market size of USD 38.74 million in 2025
The Sweden Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 14.64 million in 2025.
The Denmark Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 9.92 million in 2025
The Switzerland Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 7.09 million in 2025.
The Luxembourg Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 5.67 million in 2025.
The Rest of Europe's Urolithiasis Management Devices market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 66.13 million in 2025.
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 390.94 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033.
According to Cognitive Market Research, the China Urolithiasis Management Devices market size was valued at USD 164.19 million in 2025 and is projected to grow at a CAGR of 7.0% during the forecast period. Urolithiasis Management Devices surged in China due to increasing healthcare investments, a large patient population, and advancements in medical technology.
The Japan Urolithiasis Management Devices market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 53.95 million in 2025
The South Korean urolithiasis Management Devices market had a market share of USD 46.91 million in 2025 and is projected to grow at a CAGR of 6.6% during the forecast period. India's growth in the Urolithiasis Management Devices market is driven by increasing healthcare infrastructure, rising awareness of kidney stone treatments, and a growing population with higher prevalence of urolithiasis.
The Indian Urolithiasis Management Devices market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 39.09 million in 2025.
The Australian Urolithiasis Management Devices market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 20.33 million in 2025.
The Singapore Urolithiasis Management Devices market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 7.82 million in 2025.
The Taiwan Urolithiasis Management Devices market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 15.25 million in 2025.
The South East Asia Urolithiasis Management Devices market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 25.80 million in 2025.
The Rest of APAC Urolithiasis Management Devices market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 17.59 million in 2025.
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 61.90 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Urolithiasis Management Devices market size was valued at USD 26.49 million in 2025 and is projected to grow at a CAGR of 5.1% during the forecast period. Urolithiasis Management Devices flourished in Brazil due to increasing healthcare demand.
Argentina's Urolithiasis Management Devices market had a market share of USD 10.40 million in 2025 and is projected to grow at a CAGR of 5.4% during the forecast period. Argentina's rising healthcare demand and technology.
Colombia Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 5.51 million in 2025
Peru Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 5.08 million in 2025.
Chile Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 4.46 million in 2025
The Rest of South America's Urolithiasis Management Devices market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 9.97 million in 2025.
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 65.16 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2033..
The Qatar Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 5.21 million in 2025. Urolithiasis Management Devices sales flourish due to the healthcare advancements and demands.
The Saudi Arabia Urolithiasis Management Devices market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 22.93 million in 2025.
The Turkey Urolithiasis Management Devices market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 5.21 million in 2025. Urolithiasis Management Devices sales flourished in Turkey due to healthcare infrastructure expansion.
The UAE Urolithiasis Management Devices market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 13.42 million in 2025.
The Egypt Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 3.91 million in 2025.
The Rest of the Middle East Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 14.46 million in 2025
According to Cognitive Market Research, the global Urolithiasis Management Devices market size was estimated at USD 1628.9 Million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 35.84 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2033..
The Nigeria Urolithiasis Management Devices market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 2.87 million in 2025. Urolithiasis Management Devices sales flourish due to the healthcare advancements and demands.
The South Africa Urolithiasis Management Devices market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 12.61 million in 2025.
The Rest of Africa Urolithiasis Management Devices market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 20.35 million in 2025.
Conclusion
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Urolithiasis Management Device Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Urolithiasis Management Device Industry growth. Urolithiasis Management Device market has been segmented with the help of its Device Type Outlook:, End User Outlook: , and others. Urolithiasis Management Device market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Urolithiasis Management Devices Market?
According to Cognitive Market Research, Shock Wave Lithotripters dominate the Urolithiasis Management Devices market due to their non-invasive, effective, and safe approach to treating kidney stones. These devices utilize high-energy shock waves to break down stones into smaller fragments, which are then passed naturally through the urinary system. The increasing prevalence of urolithiasis, advancements in technology, and the preference for non-surgical treatment options drive their growing popularity. Shock Wave Lithotripters are favoured for their precision, minimal recovery time, and lower complication rates, making them the preferred choice among healthcare professionals and patients, driving their dominance in the market.
Ultrasonic lithotripters are driving the fastest growth in the Urolithiasis Management Devices Market due to their non-invasive, efficient stone fragmentation capabilities. These devices use high-frequency sound waves to break down kidney stones into smaller pieces, facilitating easier removal and minimizing patient discomfort. Their increasing adoption is fueled by their precision, lower risk of complications, and shorter recovery times compared to traditional surgical methods. Additionally, technological advancements in ultrasonic lithotripsy, such as improved targeting and energy efficiency, further enhance their appeal, making them a preferred choice for both patients and healthcare providers in managing urolithiasis.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Urolithiasis Management Device Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Hospitals dominate the Urolithiasis Management Devices market due to their primary role in treating patients with kidney stones and other urological disorders. As the largest healthcare providers, hospitals invest heavily in advanced medical devices such as lithotripters, endoscopic equipment, and robotic surgical tools. Their capacity to offer comprehensive treatment options, coupled with high patient volumes, drives demand for these devices. Additionally, hospitals often collaborate with manufacturers for customized solutions. They are equipped with the latest technology to ensure effective treatment outcomes, making them key players in the growth and adoption of urolithiasis management devices.
In the Urolithiasis Management Devices Market, Ambulatory Surgical Centers (ASCs) are rapidly driving growth due to their ability to provide cost-effective, outpatient surgical procedures. ASCs offer a faster recovery time and lower operational costs compared to traditional hospitals, making them an attractive option for treating urolithiasis (kidney stones). These centres are increasingly adopting advanced urolithiasis management devices, such as lithotripters and ureteroscopes, to improve patient outcomes. The demand for minimally invasive treatments in ASCs is rising, bolstering the market for innovative, efficient, and patient-friendly devices that enhance treatment accessibility and affordability. This trend significantly contributes to market expansion.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Disclaimer:
| Device Type Outlook: | Shock Wave Lithotripters, Ultrasonic Lithotripters, Pneumatic Lithotripters, Laser Lithotripters, Ureterorenoscopes |
| End User Outlook: | Hospitals, Ambulatory Surgical Centers (ASCs), Clinics |
| List of Competitors | * Allengers, * Boston Scientific, * BD, * Cook Medical, * ConMed, * DirexGroup, * Dornier MedTech, * KARL STORZ, * Potent Optotronic, * HealthTronics, * Lumenis, * Olympus, * Richard Wolf, * Siemens Healthcare |
Chapter 1 2026 Geopolitical Outlook - Urolithiasis Management Device Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review Global Urolithiasis Management Device Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review North America Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review Europe Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review Asia Pacific Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review South America Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review Middle East Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Urolithiasis Management Device. Further deep in this chapter, you will be able to review Middle East Urolithiasis Management Device Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Urolithiasis Management Device. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Device Type Outlook: Analysis 2019 -2031, will provide market size split by Device Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Device Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End User Outlook: Analysis 2022 - 2034
Chapter 14 Urolithiasis Management Device Price Trend Analysis
Chapter 15 Urolithiasis Management Device Import/Export Analysis
Chapter 16 Urolithiasis Management Device Production Analysis
Chapter 17 Gap Analysis
Chapter 18 Strategy Analysis
Chapter 19 Profitability and Gross Margin Analysis
Chapter 20 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Urolithiasis Management Device market
Chapter 21 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 22 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.